Literature DB >> 10952609

Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.

L Martínez-Martínez1, M C Conejo, A Pascual, S Hernández-Allés, S Ballesta, E Ramírez De Arellano-Ramos, V J Benedí, E J Perea.   

Abstract

Forty clonally related clinical isolates of Escherichia coli from hospitalized patients were resistant to cefoxitin (MICs, >256 microg/ml) and ceftazidime (MICs, 32 to 256 microg/ml) and were intermediate or resistant to cefotaxime (MICs, 16 to 128 microg/ml) but susceptible to both cefepime (MICs, 0.5 to 2 microg/ml) and imipenem (MICs, 0.125 to 0.25 microg/ml). Resistance to beta-lactams was related to high-level production of AmpC beta-lactamase and loss of OmpF porin.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10952609      PMCID： PMC90099          DOI： 10.1128/AAC.44.9.2534-2536.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.

Authors:  H Nikaido; W Liu; E Y Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.

Authors:  G A Jacoby; I Carreras
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States.

Authors:  R Cooksey; J Swenson; N Clark; E Gay; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 4.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells.

Authors:  H Nikaido; E Y Rosenberg; J Foulds
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

7.  Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes.

Authors:  J W Chow; D M Shlaes
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

8.  Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.

Authors:  J A Reguera; F Baquero; J C Pérez-Díaz; J L Martínez
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

9.  beta-Lactamases and beta-lactam resistance in Escherichia coli.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

10.  Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli.

Authors:  M Hiraoka; R Okamoto; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191
View more
  21 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.

Authors:  M Edelstein; M Pimkin; T Dmitrachenko; V Semenov; N Kozlova; D Gladin; A Baraniak; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Authors:  Laurent Poirel; Claire Héritier; Colette Spicq; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Stress and survival of aging Escherichia coli rpoS colonies.

Authors:  Claude Saint-Ruf; François Taddei; Ivan Matic
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

5.  Changes in ciprofloxacin resistance levels in Enterobacter aerogenes isolates associated with variable expression of the aac(6')-Ib-cr gene.

Authors:  Elena Ruiz; Alain A Ocampo-Sosa; Julia Alcoba-Flórez; Elena Román; Guillaume Arlet; Carmen Torres; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

6.  Inverted Regulation of Multidrug Efflux Pumps, Acid Resistance, and Porins in Benzoate-Evolved Escherichia coli K-12.

Authors:  Jeremy P Moore; Haofan Li; Morgan L Engmann; Katarina M Bischof; Karina S Kunka; Mary E Harris; Anna C Tancredi; Frederick S Ditmars; Preston J Basting; Nadja S George; Arvind A Bhagwat; Joan L Slonczewski
Journal:  Appl Environ Microbiol       Date:  2019-08-01       Impact factor: 4.792

Review 7.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Authors:  Laura Briñas; Myriam Zarazaga; Yolanda Sáenz; Fernanda Ruiz-Larrea; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Authors:  Rafael Cantón; Elena Loza; María Del Carmen Conejo; Fernando Baquero; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Ertapenem resistance of Escherichia coli.

Authors:  Marie-Frédérique Lartigue; Laurent Poirel; Claire Poyart; Hélène Réglier-Poupet; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.